Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?

被引：1
|
作者：
Dalla Pria, Alessia [1 ]
Hayward, Katy [1 ]
Bower, Mark [1 ]
机构：
[1] Chelsea & Westminster Hosp, Natl Ctr HIV Malignancy, London SW10 9NH, England
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2013年 / 13卷 / 02期
关键词：
AIDS; antiretrovirals; chemotherapy; HIV; Kaposi sarcoma; ACTIVE ANTIRETROVIRAL THERAPY; RECONSTITUTION INFLAMMATORY SYNDROME; PEGYLATED-LIPOSOMAL DOXORUBICIN; VASCULAR-PERMEABILITY FACTOR; PHASE-III TRIAL; IMMUNE RECONSTITUTION; DNA-SEQUENCES; MALIGNANCY CONSORTIUM; INFECTED INDIVIDUALS; PROTEASE INHIBITORS;
D O I：
10.1586/ERA.12.179
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The widespread introduction of effective combination antiretroviral therapy (cART) has had a major influence on the epidemiology and natural history of AIDS-associated Kaposi's sarcoma (AIDS-KS). cART has reduced the incidence of AIDS-KS, and it has been shown to be an effective treatment for early-stage KS. So with the widespread availability of cART, is systemic chemotherapy still required for AIDS-KS? Two indications appear to remain: advanced-stage AIDS-KS and patients who have progressive KS despite effective cART including immune reconstitution inflammatory syndrome KS.
引用
收藏
页码：203 / 209
页数：7
相关论文
共 50 条
  • [31] Human herpesvirus 8 detection in patients diagnosed with AIDS-associated Kaposi's sarcoma or AIDS-associated Castleman's disease
    Briz, M
    Martin, T
    Yebra, M
    Laguna, P
    Busto, MJ
    Fernandez, MN
    MEDICINA CLINICA, 1998, 110 (17): : 662 - 664
  • [32] HAART is the centre of graduated systemic treatment of AIDS-associated Kaposi's sarcoma
    不详
    Drugs & Therapy Perspectives, 2005, 21 (8) : 14 - 17
  • [33] Intralesional vinblastine for treating AIDS-associated Kaposi's sarcoma of the oropharynx and larynx
    Friedman, M
    Venkatesan, TK
    Caldarelli, DD
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1996, 105 (04): : 272 - 274
  • [34] The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma
    Aboulafia, DM
    CHEST, 2000, 117 (04) : 1128 - 1145
  • [35] HIV/AIDS-associated Kaposi's sarcoma of the gastrointestinal tract: A pictorial spectrum
    Patel, N.
    Naidoo, P.
    Mosiane, P.
    Jann-Kruger, C.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2016, 106 (10): : 53 - 54
  • [36] Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma - Reply
    Friborg, J
    Nabel, GJ
    Nickoloff, BJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (25): : 1838 - 1839
  • [37] Effects of Chemotherapy in AIDS-Associated Non-Hodgkin's Lymphoma on Kaposi's Sarcoma Herpesvirus DNA in Blood
    Lin, Lan
    Lee, Jeannette Y.
    Kaplan, Lawrence D.
    Dezube, Bruce J.
    Noy, Ariela
    Krown, Susan E.
    Levine, Alexandra M.
    Yu, Yanxing
    Hayward, Gary S.
    Ambinder, Richard F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2496 - 2502
  • [38] The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
    Dupin, N
    De Cervens, VR
    Gorin, I
    Calvez, V
    Pessis, E
    Grandadam, M
    Rabian, C
    Viard, JP
    Huraux, JM
    Escande, JP
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 140 (05) : 875 - 881
  • [39] AIDS-associated Kaposi's sarcoma cells secrete a neurotrophic growth factor(s)
    Weeks, BS
    Cooney, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (02) : 408 - 412
  • [40] Gender differences in AIDS-associated Kaposi sarcoma in Harare, Zimbabwe
    Meditz, Amie L.
    Borok, Margaret
    MaWhinney, Samantha
    Gudza, Ivy
    Ndemera, Buxton
    Gwanzura, Lovemore
    Camphell, Thomas B.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (03) : 306 - 308
12345